Skip to main content
. Author manuscript; available in PMC: 2021 May 17.
Published in final edited form as: Stat Methods Med Res. 2018 Oct 8;28(10-11):3318–3332. doi: 10.1177/0962280218801134

Table 1.

Predicted oral-PrEP effectiveness in men (based on the lower confidence limits in Figure 1) for different assumed adherence, and suggested NI margins that preserve at least 50% of the benefit (ρ = 0.5).

Adherence Effectiveness (M1) NI Margin (M2)
0.40 <1.0 1.0
0.50 1.17 1.08
0.60 1.50 1.23
0.70 1.89 1.37
0.80 2.30 1.52